Department of Urology
Arnulf Stenzl has not added Biography.
If you are Arnulf Stenzl and would like to personalize this page please email our Author Liaison for assistance.
Giant solitary tumor in the true pelvis: atypical prostatic adenomyomatosis.
Urologia internationalis , 2007 | Pubmed ID: 17293665
Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
BJU international Aug, 2008 | Pubmed ID: 18410442
[Photodynamic diagnostics in the urinary tract. Consensus paper of the Working Group for Oncology of the German Society for Urology].
Der Urologe. Ausg. A Aug, 2008 | Pubmed ID: 18587549
Can we still afford bladder cancer?
Current opinion in urology Sep, 2008 | Pubmed ID: 18670272
Cystectomy in women.
BJU international Nov, 2008 | Pubmed ID: 19035894
The updated EAU guidelines on muscle-invasive and metastatic bladder cancer.
European urology Apr, 2009 | Pubmed ID: 19157687
Interpretation of the prostate cancer gene 3 in reference to the individual clinical background: implications for daily practice.
Urologia internationalis , 2010 | Pubmed ID: 20424427
Small renal oncocytomas: differentiation with multiphase CT.
European journal of radiology Nov, 2011 | Pubmed ID: 20667676
Words of wisdom. Re: sex and racial differences in bladder cancer presentation and mortality in the US.
European urology Apr, 2010 | Pubmed ID: 20965044
Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results.
International braz j urol : official journal of the Brazilian Society of Urology Sep-Oct, 2010 | Pubmed ID: 21044370
Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.
Cancer Mar, 2011 | Pubmed ID: 21351082
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.
European urology Jun, 2011 | Pubmed ID: 21454009
Influence of renal excretory function on the performance of urine based markers to detect bladder cancer.
The Journal of urology Jan, 2012 | Pubmed ID: 22088333
[Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines].
Actas urologicas espanolas Sep, 2012 | Pubmed ID: 22386114
Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?
World journal of urology Apr, 2013 | Pubmed ID: 22407328
Isolated, disseminated and circulating tumour cells in prostate cancer.
Nature reviews. Urology Aug, 2012 | Pubmed ID: 22777287
Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
Cancer cytopathology May, 2013 | Pubmed ID: 23172833
Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
BJU international Jan, 2014 | Pubmed ID: 23360112
The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature.
European urology Aug, 2014 | Pubmed ID: 23735200
A double-blind, randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy.
The oncologist , 2013 | Pubmed ID: 24105751
Long-term results after endoscopic VUR-treatment using dextranomer / hyaluronic acid copolymer - 5-year experience in a single-center.
Central European journal of urology , 2011 | Pubmed ID: 24578870
Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy.
European journal of cancer (Oxford, England : 1990) Oct, 2014 | Pubmed ID: 25088206
Prevention and early detection of prostate cancer.
The Lancet. Oncology Oct, 2014 | Pubmed ID: 25281467
Role of 11C-choline positron emission tomography in prostate cancer recurrence--potential for delayed cure or just resetting the clock of the disease?
The Journal of urology Jan, 2015 | Pubmed ID: 25444969
Mesenchymal stromal cells for sphincter regeneration.
Advanced drug delivery reviews Mar, 2015 | Pubmed ID: 25451135
Quality of life outcomes after radical cystectomy: long-term standardized assessment of Studer Pouch versus I-Pouch.
World journal of urology Oct, 2015 | Pubmed ID: 25501497
Urethral recurrence in women with orthotopic bladder substitutes: A multi-institutional study.
Urologic oncology May, 2015 | Pubmed ID: 25744654
Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer.
BMC cancer Mar, 2015 | Pubmed ID: 25884545
Immunohistochemical assessment of lymphatic and blood vessel invasion in T1 urothelial carcinoma of the bladder.
Scandinavian journal of urology , 2015 | Pubmed ID: 25921278
The "I-Pouch": Results of a new ileal neobladder technique.
Scandinavian journal of urology , 2015 | Pubmed ID: 25921359
Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?
BJU international Jul, 2015 | Pubmed ID: 26123071
Considerations for orthotopic diversions in women.
Current opinion in urology Nov, 2015 | Pubmed ID: 26375059
Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Clinical genitourinary cancer Feb, 2016 | Pubmed ID: 26506908
Words of Wisdom. Re: Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
European urology Mar, 2016 | Pubmed ID: 26867725
Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
Journal of cancer research and clinical oncology May, 2016 | Pubmed ID: 26910601
Minimally invasive versus conventional large-bore percutaneous nephrolithotomy in the treatment of large-sized renal calculi: Surgeon's preference?
Scandinavian journal of urology Jun, 2016 | Pubmed ID: 27010782
Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease.
World journal of urology Mar, 2017 | Pubmed ID: 27043218
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
European urology 04, 2017 | Pubmed ID: 27720534
Pathophysiology and Contributing Factors in Postprostatectomy Incontinence: A Review.
European urology 06, 2017 | Pubmed ID: 27720536
Critical Review of Outcomes from Radical Cystectomy: Can Complications from Radical Cystectomy Be Reduced by Surgical Volume and Robotic Surgery?
European urology focus Apr, 2016 | Pubmed ID: 28723446
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.
Urologic oncology 12, 2017 | Pubmed ID: 28889922
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2017 | Pubmed ID: 28902533
Optical improvements in the diagnosis of bladder cancer: implications for clinical practice.
Therapeutic advances in urology Nov, 2017 | Pubmed ID: 29662543
Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
International journal of cancer 12, 2018 | Pubmed ID: 30070687
mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance.
Journal of cancer research and clinical oncology Jan, 2019 | Pubmed ID: 30368665
Automated Definition of Skeletal Disease Burden in Metastatic Prostate Carcinoma: A 3D Analysis of SPECT/CT Images.
Cancers Jun, 2019 | Pubmed ID: 31234424
PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma.
Cancer immunology research Nov, 2019 | Pubmed ID: 31484656
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases.
World journal of urology Aug, 2020 | Pubmed ID: 31691084
Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer.
World journal of urology Oct, 2020 | Pubmed ID: 31907632
Preservation of the bladder, but at what cost?
Translational andrology and urology Dec, 2019 | Pubmed ID: 32042621
Human Prostate Cancer is Characterized by an Increase in Urea Cycle Metabolites.
Cancers 07, 2020 | Pubmed ID: 32640711
Role of Multiparametric Magnetic Resonance Imaging in Predicting Pathologic Outcomes in Prostate Cancer.
The world journal of men's health Jan, 2021 | Pubmed ID: 32648376
Prognostic impact of somatostatin receptor expression in advanced bladder cancer.
Urologic oncology 12, 2020 | Pubmed ID: 32773234
Transcript Levels of Aldo-Keto Reductase Family 1 Subfamily C (AKR1C) Are Increased in Prostate Tissue of Patients with Type 2 Diabetes.
Journal of personalized medicine Sep, 2020 | Pubmed ID: 32932589
Characterization of Hormone-Dependent Pathways in Six Human Prostate-Cancer Cell Lines: A Gene-Expression Study.
Genes 10, 2020 | Pubmed ID: 33036464
Increased Expressions of Matrix Metalloproteinases (MMPs) in Prostate Cancer Tissues of Men with Type 2 Diabetes.
Biomedicines Nov, 2020 | Pubmed ID: 33207809
Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
European urology 06, 2021 | Pubmed ID: 33422353
Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report.
Journal for immunotherapy of cancer 01, 2021 | Pubmed ID: 33431630
Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial.
European urology 03, 2021 | Pubmed ID: 33461782
Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma.
Expert opinion on biological therapy Sep, 2021 | Pubmed ID: 33576709
Minimal-invasive management of urological complications after kidney transplantation.
International urology and nephrology Jul, 2021 | Pubmed ID: 33655463
Injection of Porcine Adipose Tissue-Derived Stromal Cells by a Novel Waterjet Technology.
International journal of molecular sciences Apr, 2021 | Pubmed ID: 33921246
Treatment of Stress Urinary Incontinence with Muscle Stem Cells and Stem Cell Components: Chances, Challenges and Future Prospects.
International journal of molecular sciences Apr, 2021 | Pubmed ID: 33921532
Comparison of the metabolome in urine prior and eight weeks after radical prostatectomy uncovers pathologic and molecular features of prostate cancer.
Journal of pharmaceutical and biomedical analysis Oct, 2021 | Pubmed ID: 34371449
Micro-Ultrasound: a way to bring imaging for prostate cancer back to urology.
Prostate international Jun, 2021 | Pubmed ID: 34386446
Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.
The Lancet. Oncology 09, 2021 | Pubmed ID: 34388386
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved